Top Articles

Volume 116, Number 3- PROGRESS IN HEMATOLOGY –

Guest editorial: prophylaxis and treatment of relapse after allogeneic hematopoietic stem cell transplantation (by Daigo Hashimoto)

Anti-programmed cell death-1 monoclonal antibody therapy before or after allogeneic hematopoietic cell transplantation for classic Hodgkin lymphoma: a literature review (by Ayumu Ito, et al.)

Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation (by Xing-yu Cao, et al.)

Relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia: an overview of prevention and treatment (by Firas Kreidieh, et al.)

FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation (by Francesca Biavasco and Robert Zeiser)

Volume 116, Number 2- PROGRESS IN HEMATOLOGY –

The path from stem cells to red blood cells (by Hideo Harigae)

The role of specialized cell cycles during erythroid lineage development: insights from single-cell RNA sequencing (by Merav Socolovsky)

Heme as a differentiation-regulatory transcriptional cofactor (by Ruiqi Liao and Emery H. Bresnick)

The mutual crosstalk between iron and erythropoiesis (by Clara Camaschella, et al.)

Induction of enucleation in primary and immortalized erythroid cells (by Svetlana Soboleva and Kenichi Miharada)

Volume 116, Number 1- PROGRESS IN HEMATOLOGY –

Guest editorial: current status and future perspectives of allogeneic hematopoietic cell transplantation for non-malignant diseases (by Katsutsugu Umeda)

Conditioning regimens for inborn errors of immunity: current perspectives and future strategies (by Akira Nishimura, et al.) 

Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes (by  Hirotoshi Sakaguchi and  Nao Yoshida)

Allogeneic hematopoietic stem cell transplantation for inherited metabolic disorders (by Hiromasa Yabe)

Unresolved issues in allogeneic hematopoietic cell transplantation for non-malignant diseases (by Katsutsugu Umeda) 

Volume 115, Number 6- PROGRESS IN HEMATOLOGY –

Guest Editorial: Innovation will be a bridge to cure in patients with multiple myeloma? (by Hiroyuki Takamatsu)

Multiple myeloma with high-risk cytogenetics and its treatment approach (by Ichiro Hanamura) 

Progress of modern imaging modalities in multiple myeloma (by Toshiki Terao and Kosei Matsue)  

Bringing mass spectrometry into the care of patients with multiple myeloma (by David L. Murray)

Novel immunotherapies in multiple myeloma (by Ken Ohmine and Ryosuke Uchibori) 

Volume 115, Number 5- PROGRESS IN HEMATOLOGY –

Philadelphia chromosome-negative myeloproliferative neoplasms: clinical aspects and treatment options (by Akihiko Gotoh)

Improving allogeneic stem cell transplantation in myelofibrosis (by Nico Gagelmann and Nicolaus Kröger)

Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives (by Giuseppe G. Loscocco and Alessandro M. Vannucchi)

Novel treatments for myelofibrosis: beyond JAK inhibitors (by Douglas Tremblay and Ruben Mesa)

Treatment options and pregnancy management for patients with PV and ET (by Yoko Edahiro)

Volume 114, Number 5- PROGRESS IN HEMATOLOGY –

Efforts to maximize the potential of CAR-T therapy for cancer, from T-bodies to CAR-immune cells (by Hiroshi Fujiwara)

Next-generation CAR T cells to overcome current drawbacks (by Stefan Lundh, et al.)

Development of CMV-CD19 bi-specific CAR T cells with post-infusion in vivo boost using an anti-CMV vaccine (by Xiuli Wang, et al.)

Engineering the next generation of CAR-NK immunotherapies (by Alexander Biederstädt and Katayoun Rezvani)

Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors (by Tatsuki Ueda and Shin Kaneko)

Volume 113, Number 5- PROGRESS IN HEMATOLOGY –

Evolution of CML treatment (by Shinya Kimura) 

Current status and novel strategy of CML (by Kiyomi Morita and Koji Sasaki)

Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia (by Hyewon Lee, et al.)

Treatment-free remission and immunity in chronic myeloid leukemia (by Hiroshi Ureshino)

New routes to eradicating chronic myelogenous leukemia stem cells by targeting metabolism  (by Kazuhito Naka)

Volume 113, Number 1- PROGRESS IN HEMATOLOGY –

 Diversity of disseminated intravascular coagulaton and selection of appropriate treatments (by Hidesaku Asakura)

Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations (by Shinya Yamada and Hidesaku Asakura)

Recent advances in the research and management of sepsis-associated DIC (by Toshiaki Iba, et al.)

Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies (by Takayuki Ikezoe)

COVID-19-associated coagulopathy and disseminated intravascular coagulation (by Hidesaku Asakura and Haruhiko Ogawa)

Volume 111, Number 5- PROGRESS IN HEMATOLOGY –

Guest editorial: B1 cells: their ontogeny and malignant counterpart (by Naoyuki Katayama)

The ontogeny of murine B-1a cells (by Momoko Yoshimoto)

Ontogeny of human B1 cells (by Yuki Kageyama  and Naoyuki Katayama)

Pathophysiology of chronic lymphocytic leukemia and human B1 cell development (by Yoshikane Kikushige)

Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal? (by Junji Suzumiya and Jun Takizawa)

Volume 111, Number 4- PROGRESS IN HEMATOLOGY –

Introduction by the Guest Editor: Recent advances in biology and treatment of multiple myeloma (by Hirokazu Tanaka)

Molecular basis of clonal evolution in multiple myeloma (by Yusuke Furukawa and Jiro Kikuchi)

Latest treatment strategies aiming for a cure in transplant-eligible multiple myeloma patients: how I cure younger MM patients with lower cost (by Kenshi Suzuki) 

Clinical value of measurable residual disease testing for multiple myeloma and implementation in Japan (by Hiroyuki Takamatsu)

Chimeric antigen receptor T-cell therapy for multiple myeloma (by Naoki Hosen)

Volume 111, Number 2- PROGRESS IN HEMATOLOGY -

Progress in elucidation of molecular pathophysiology and its application in therapeutic decision-making for myeloproliferative neoplasms (by Katsuto Takenaka)

Progress in elucidation of molecular pathophysiology of myeloproliferative neoplasms and its application to therapeutic decisions (by Ruochen Jia and Robert Kralovics)

Mutational profiling in myelofibrosis: implications for management (by Prithviraj Bose and Srdan Verstovsek)

The role of calreticulin mutations in myeloproliferative neoplasms (by Marito Araki and Norio Komatsu)

The role of driver mutations in myeloproliferative neoplasms: insights from mouse models (by Kotaro Shide)

Volume 111, Number 1- PROGRESS IN HEMATOLOGY -

Current progress and future direction in the treatment for hemophilia (by Midori Shima)

Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity (by Takehisa Kitazawa and Midori Shima)

Advances in gene therapy for hemophilia: basis, current status, and future perspectives (by Tsukasa Ohmori)

Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia (by Pratima Chowdary)

Volume 110, Number 2- PROGRESS IN HEMATOLOGY -

Epigenetic abnormalities and therapies for hematological malignancies (by Toshio Kitamura)

New insights into the biology of acute myeloid leukemia with mutated NPM1 (by Lorenzo Brunetti, et al.)

Clinical update on hypomethylating agents (by Matthieu Duchmann and Raphael Itzykson)

Deregulated Polycomb functions in myeloproliferative neoplasms (by Goro Sashida, et al.)

Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms (by Shuhei Asada and Toshio Kitamura)

Volume 110, Number 1- PROGRESS IN HEMATOLOGY -

Guest Editorial: Are “alternative” stem cell sources still alternative in the new era? (by Junya Kana)
Effect of antithymocyte globulin on HLA-mismatched unrelated transplantation (by Koji Kawamura)
HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide (by Junichi Sugita)
Single cord blood transplantation in Japan; expanding the possibilities of CBT (by Hisashi Yamamoto)
Current and future perspectives on allogeneic transplantation using ex vivo expansion or manipulation of umbilical cord blood cells (by Ko K. Maung and Mitchell E. Horwitz)

Volume 109, Number 1- PROGRESS IN HEMATOLOGY -

Molecular pathogenesis of leukemia and leukemic stem cells (LSCs) (by Masahiro Kizaki)
Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia (by Tze King Tan, et al.)
Metabolism as master of hematopoietic stem cell fate (by Kyoko Ito, et al.)
Targeting transcription factors in acute myeloid leukemia (by Hisashi Takei and Susumu S. Kobayashi)
What do the lineage tracing studies tell us? Consideration for hematopoietic stem cell origin, dynamics, and leukemia-initiating cells (by Nathalia Azevedo Portilho, et al.)

Working on a manuscript?

Avoid the most common mistakes and prepare your manuscript for journal editors.

Learn more